As of Jan 13
| +0.36 / +0.89%|
The 26 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 47.61, with a high estimate of 55.11 and a low estimate of 35.83. The median estimate represents a +17.11% increase from the last price of 40.65.
The current consensus among 28 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.